期刊文献+

亚砷酸治疗急性早幼粒细胞白血病临床疗效及不良反应 被引量:5

暂未订购
导出
摘要 目的探讨急性早幼粒细胞白血病患者行亚砷酸治疗的疗效与不良反应。方法将40例急性早幼粒细胞白血病患者随机分为对照组与观察组,对照组(n=16)行维甲酸联合化疗治疗,观察组(n=24)给予亚砷酸治疗,观察2组患者的临床疗效与不良反应情况。结果 2组患者经治疗后,对照组与观察组治疗有效率分别为75.0%、100.0%,观察组复发病例行亚砷酸治疗后的治疗有效率达75.0%;对照组完全缓解时间为(37.8±4.0)d,显著高于观察组的(26.9±3.7)d;对照组DIC、高白细胞综合征发生率显著高于观察组(均P<0.05);患者用药后的不良反应多为一过性,经对症处理后明显改善且无需停药。结论急性早幼粒细胞白血病患者行亚砷酸治疗后,可有效缩短患者完全缓解时间,提高治疗有效率,与维甲酸联合化疗治疗时未见交叉耐药,且未见严重不良反应,疗效确切,值得推广。
出处 《当代医学》 2015年第18期138-139,共2页 Contemporary Medicine
  • 相关文献

参考文献8

二级参考文献51

共引文献327

同被引文献50

  • 1吕在明,张曦,陈幸华,刘林.亚砷酸治疗急性早幼粒细胞白血病的临床观察[J].重庆医学,2004,33(9):1399-1400. 被引量:2
  • 2冯翠,张华,李虎生,等.全反式维甲酸联合亚砷酸治疗急性早幼粒细胞白血病的临床疗效[J].医学信息(下旬刊),2013,26(15):492.
  • 3DE THt H, LE BRAS M, LALLEMAND-BREITENBACH V. The cellbiology of disease: Acute promyelocytic leukemia, arse- nic, andPMLbodies[J]. JCellBiol, 2012, 198(1): 11 -21.
  • 4CUNNINGHAM I, GEE TS, REICH LM, et al. Acute promyelo- cytic leukemia: treatment results during a decade at Memorial Hospital[J]. Blood, 1989, 73(5) :1116-1122.
  • 5LO-COCO F. Retinoic acid and arsenic trioxide for acute promye- loeytic leukemia[J]. N Engl J Med, 2013, 369(2) : 111 - 121.
  • 6ASOU N, KISHIMOTO Y, K1YOI H,et al. A randomized study with or without intensified maintenance chemotherapy in patients with acute promyelocytic leukemia who have become negative for PML-RARalpha transcript after consolidation therapy: the Japan Adult Leukemia Study Group(JALSG) APL97 study [ J ]. Blood, 2007, 110(1):59-66.
  • 7ADES L, GUERCI A, RAFFOUX E, et al. Very long-term out- come of acute promyelocytic leukemia after treatment with all- trans retinoic acid and chemotherapy: the European APL Group experience[J]. Blood, 2010, 115(9) :1690-1696.
  • 8AVVISATI G, LO-COCO F, PAOLONI FP, et al. AIDA 0493 protocol for newly diagnosed acute promyelocytic leukemia: very longterm results and role of maintenance [ J ]. Blood, 2011, 117 (18) :4716 -4725.
  • 9BURNETT AK, HILLS RK, GRIMWADE D,et al. Inclusion of chemotherapy in addition to anthracycline in the treatment of pro- myelocytic leukaemia does not improve outcomes: results of the MRC AML15 trial[ J]. Leukemia, 2013, 27 (4) :843 - 851.
  • 10SOIGNET SL, FRANKEL SR, DOUER D, et al. United States muhicenter study of arsenic trioxide in relapsed acute promyelo- cytic leukemia[ J]. J Clin Oncol, 2001, 19 (18) :3852 - 3860.

引证文献5

二级引证文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部